Skip to content

Clinical trials

Endometrial Neoplasms trials in Brazil

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Endometrial Neoplasms Country / region: Brazil Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20112
20121
20141
20161
20171
20181
20191
20202
20211
20221
20232
20242
20256
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting9
Completed5
Active, not recruiting4
Unknown status2
Withdrawn1
Not yet recruiting1
Suspended1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Merck Sharp & Dohme LLC4
AstraZeneca3
AC Camargo Cancer Center2
Novartis Pharmaceuticals2
BioNTech SE1
Brazilian National Cancer Institute1
Daiichi Sankyo1
Eisai Inc.1
Genmab1
Gilead Sciences1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Endometrial Neoplasms24
Uterine Neoplasms5
Ovarian Neoplasms4
Neoplasms3
Recurrence3
Uterine Cervical Neoplasms3
Breast Neoplasms2
Obesity2
Biliary Tract Neoplasms1
Carcinoma1

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.